B. Delahunt

B. Delahunt, A. Hill, A. Phillips, 2011, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

Intraductal carcinoma of the prostate: a critical re-appraisal

B. Delahunt, G. Kristiansen, H. Samaratunga, 2019, Virchows Archiv.

Nucleolar Grade But Not Fuhrman Grade is Applicable to Papillary Renal Cell Carcinoma

B. Delahunt, Dianne Sika-Paotonu, M. McCredie, 2006, The American journal of surgical pathology.

Active surveillance for prostate cancer: the role of the pathologist.

M. Rubin, A. Chinnaiyan, B. Delahunt, 2015, Pathology.

Communicating prostate biopsy results

B. Delahunt, M. Varma, A. Warren, 2021, Diagnostic Histopathology.

Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy.

B. Delahunt, H. Samaratunga, L. Egevad, 2020, Pathology.

Borderline Gleason scores: communication is the key

B. Delahunt, D. Berney, T. H. van der Kwast, 2020, Journal of Clinical Pathology.

Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded.

B. Delahunt, D. Bostwick, J. Kench, 2019, Pathology.

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.

B. Delahunt, C. Oldmeadow, J. Attia, 2019, The Lancet. Oncology.

Reporting intraductal carcinoma of the prostate: a plea for greater standardization

B. Delahunt, G. Kristiansen, M. Varma, 2017, Histopathology.

Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases

B. Delahunt, H. Samaratunga, J. Srigley, 2016, Histopathology.

The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer

B. Delahunt, H. Samaratunga, L. Egevad, 2015, Pathology.

Active surveillance guidance for New Zealand men with low-risk prostate cancer.

B. Delahunt, J. Matthews, J. Nacey, 2015, The New Zealand medical journal.

Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases

B. Delahunt, H. Samaratunga, J. Nacey, 2014, Histopathology.

International Society of Urological Pathology (ISUP) consensus conference on renal neoplasia: rationale and organization.

B. Delahunt, J. Srigley, L. Egevad, 2013, The American journal of surgical pathology.

Tertiary Gleason pattern 5 on needle biopsy predicts greater tumour volume on radical prostatectomy

B. Delahunt, H. Samaratunga, M. Brunelli, 2011, Pathology.

Distal seminal vesicle invasion by prostate adenocarcinoma does not occur in isolation of proximal seminal vesicle invasion or lymphovascular infiltration

B. Delahunt, H. Samaratunga, J. Yaxley, 2010, Pathology.

Grading prostate biopsies with artificial 1 intelligence : a diagnostic study 2

P. Ruusuvuori, P. Ström, H. Olsson, 2019 .

Prostate cancer screening in Australasia.

B. Delahunt, J. Denham, D. Lamb, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.

B. Delahunt, M. McCredie, J. Eble, 2001, Human pathology.

Gene of the month: DICER1: ruler and controller

B. Delahunt, M. Thunders, 2020, Journal of Clinical Pathology.

Early berry aneurysm formation in Marfan's syndrome.

B. Delahunt, W. Stehbens, A. Hilless, 1989, Surgical neurology.

Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study

B. Delahunt, C. Porta, M. Fassan, 2022, Journal of personalized medicine.

MicroRNAs in Mesenteric Lymph and Plasma During Acute Pancreatitis

B. Delahunt, C. Blenkiron, J. Windsor, 2014, Annals of surgery.

[The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].

B. Delahunt, P. Humphrey, G. Kristiansen, 2016, Der Pathologe.

Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-I dysfunction.

B. Delahunt, Yannan Jiang, A. Phillips, 2016, World journal of gastroenterology.

Dysplastic and Malignant Areas in Hyperplastic Polyps of the Large Intestine

B. Delahunt, W. Isbister, H. Teoh, 1989, Pathology.

Emerging entities of renal cell neoplasia

B. Delahunt, H. Samaratunga, L. Egevad, 2019, Surgical and Experimental Pathology.

The evolving classification of renal cell neoplasia.

B. Delahunt, J. Srigley, 2015, Seminars in diagnostic pathology.

Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin.

A. Renshaw, B. Delahunt, D. Grignon, 2010, Archives of pathology & laboratory medicine.

Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses.

B. Delahunt, Liang Cheng, J. Eble, 2010, American journal of clinical pathology.

Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma

B. Delahunt, Liang Cheng, J. Eble, 2007, Modern Pathology.

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy

B. Delahunt, H. Samaratunga, L. Egevad, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Value of uroplakin III in distinguishing variants of primary bladder urothelial carcinoma from malignancy metastatic to the urinary bladder.

B. Delahunt, H. Samaratunga, Michael Adamson, 2014, Anticancer research.

Personalized histopathology reporting for personalized medicine: a plea for improved communication

B. Delahunt, D. Berney, M. Varma, 2020, Virchows Archiv.

Renal cell carcinoma: I. Clinical indicators of prognosis.

B. Delahunt, J. Nacey, 1986, The New Zealand medical journal.

Serum creatine kinase levels parallel the clinical course for rhabdomyomatous Wilms tumor.

B. Delahunt, E. Wiltshire, K. Pringle, 2001, American journal of clinical pathology.

Macroscopic features of prostate cancer.

B. Delahunt, L. Egevad, C. Lindh, 2018, Pathology.

Re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1.

B. Delahunt, H. Samaratunga, J. Srigley, 2017, European urology.

Re: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade: A. Zietman, E. Klein, M. J. Droller, P. Dasgupta, J. Catto and J. A. Smith, Jr. J Urol 2016;195: 1723.

B. Delahunt, H. Samaratunga, J. Srigley, 2016, The Journal of urology.

Reply: Gleason and Fuhrman no longer make the grade

B. Delahunt, H. Samaratunga, J. Srigley, 2016, Histopathology.

New Gleason grading system: Statement from the editors of 6 journals.

B. Delahunt, H. Samaratunga, J. Srigley, 2016, Urologic oncology.

Somatic alterations detected in diagnostic prostate biopsies provide an inadequate representation of multifocal prostate cancer

B. Delahunt, H. Samaratunga, J. Lindberg, 2019, The Prostate.

Findings in 1,123 Men with Preoperative 68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography and Multiparametric Magnetic Resonance Imaging Compared to Totally Embedded Radical Prostatectomy Histopathology: Implications for the Diagnosis and Management of Pros

B. Delahunt, H. Samaratunga, L. Egevad, 2021, The Journal of urology.

Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists

B. Delahunt, D. Grignon, J. Srigley, 2018, The American journal of surgical pathology.

How cost effective are routine preoperative investigations?

B. Delahunt, P. R. Turnbull, P. Turnbull, 1980, The New Zealand medical journal.

THE REDOX STATUS OF EXPERIMENTAL HEMORRHAGIC SHOCK AS MEASURED BY CYCLIC VOLTAMMETRY

B. Delahunt, J. Windsor, G. Cooper, 2009, Shock.

Intragenic PTEN/MMAC1 Loss of Heterozygosity in Conventional (Clear-Cell) Renal Cell Carcinoma is Associated with Poor Patient Prognosis

B. Delahunt, B. Mciver, S. Grebe, 2002, Modern Pathology.

AgNORs, and Tumor Stage and Grade as Prognostic Markers for Renal Cell Carcinoma

B. Delahunt, P. Bethwaite, 1997 .

Nucleolar organizer regions and prognosis in renal cell carcinoma

B. Delahunt, P. Bethwaite, J. Ribas, 1991, The Journal of pathology.

Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: Comparison with tumour grade, mitotic index, and silver‐staining nucleolar organizer region numbers

B. Delahunt, J. Nacey, P. Bethwaite, 1993, The Journal of pathology.

Granular necrosis: a distinctive form of cell death in malignant tumours.

B. Delahunt, D. Berney, A. Evans, 2020, Pathology.

Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists

Brett Hemamali David J. Andrew J. Daniel M. Chin-Chen Gl Delahunt Samaratunga Grignon Evans Berney P, G. Litjens, J. A. van der Laak, 2020, Modern Pathology.

Analysis of the prevalence of voiding symptoms in Maori, Pacific Island, and Caucasian New Zealand men.

B. Delahunt, J. Nacey, P. Morum, 1995, Urology.

Inactivation of CD4+CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load

Kylie M. Quinn, B. Delahunt, B. Buddle, 2006, Immunology and cell biology.

Issues and challenges associated with classifying neoplasms in percutaneous needle biopsies of incidentally found small renal masses.

B. Delahunt, A. Evans, J. Srigley, 2015, Seminars in diagnostic pathology.

Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists

B. Delahunt, D. Berney, P. Humphrey, 2015, Histopathology.

Grading of renal cell carcinoma

B. Delahunt, H. Samaratunga, L. Egevad, 2018, Histopathology.

Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies.

B. Delahunt, 1999, Pathology.

Gene of the month: TMPRSS2 (transmembrane serine protease 2)

B. Delahunt, M. Thunders, 2020, Journal of Clinical Pathology.

Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer.

J. Logan, B. Delahunt, H. Samaratunga, 2022, Pathology.

Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2.

B. Delahunt, R. Flavell, B. Bäckström, 2002, International immunology.

Ductal adenocarcinoma of the prostate: current opinion and controversies.

B. Delahunt, H. Samaratunga, 2008, Analytical and quantitative cytology and histology.

CTLA-4 Blockade Enhances the Immune Response Induced by Mycobacterial Infection but Does Not Lead to Increased Protection

B. Delahunt, I. Orme, S. Hook, 1999, Infection and Immunity.

The future of computational pathology: expectations regarding the anticipated role of artificial intelligence in pathology by 2030

J. A. van der Laak, B. Delahunt, K. Iczkowski, 2022, medRxiv.

EDITORIAL Current management of hepatitis C in New Zealand

B. Delahunt, P. Joyce, R. Jackson, 2001 .

Ductal adenocarcinoma of the prostate—reply

B. Delahunt, H. Samaratunga, J. Yaxley, 2011 .

LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia.

B. Delahunt, G. Kristiansen, Katia R. M. Leite, 2022, Pathology.

Smooth muscle cell depletion and collagen types in progeric arteries.

B. Delahunt, E. Gilbert-Barness, W. Stehbens, 2001, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Aortic aneurysm in systemic lupus erythematosus

B. Delahunt, W. Stehbens, W. Shirer, 1993, Histopathology.

The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel

B. Delahunt, D. Berney, J. Srigley, 2017, Histopathology.

The WHO 2016 Classification of Testicular Germ Cell Tumours: a Review and Update from the ISUP Testis Consultation Panel

B. Delahunt, D. Berney, J. Srigley, 2016 .

Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.

B. Delahunt, D. Grignon, J. McKenney, 2017, Human pathology.

Recently described and unusual variants of urothelial carcinoma of the urinary bladder.

B. Delahunt, H. Samaratunga, 2012, Pathology.

Allergen-Specific CTL Require Perforin Expression To Suppress Allergic Airway Inflammation

B. Delahunt, J. Ma, F. Ronchese, 2012, The Journal of Immunology.

InflammationExpression To Suppress Allergic Airway Allergen-Specific CTL Require Perforin

B. Delahunt, J. Ma, F. Ronchese, 2012 .

Proliferation of renal cell carcinoma assessed by fixation‐resistant polyclonal Ki‐67 antibody labeling. Correlation with clinical outcome

B. Delahunt, P. Bethwaite, J. Ribas, 1995, Cancer.

Role of Eosinophils in the Pathogenesis ofMycobacterium bovis BCG Infection in Gamma Interferon Receptor-Deficient Mice

B. Delahunt, G. Le Gros, J. Kirman, 2000, Infection and Immunity.

IL‐4, IL‐5 and IL‐10 are not required for the control of M. bovis‐BCG infection in mice

B. Delahunt, Wangxue Chen, G. Le Gros, 1998, Immunology and cell biology.

Demographic and clinical factors as determinants of serum levels of prostate specific antigen and its derivatives.

B. Delahunt, P. Weinstein, J. Nacey, 2004, Anticancer research.

Assessment of ethnic variation in serum levels of total, complexed and free prostate specific antigen. Comparison of Maori, Pacific Island and New Zealand European populations

B. Delahunt, P. Weinstein, R. Cooke, 2003, Pathology.

ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms

B. Delahunt, K. Filbey, W. Weninger, 2015, Nature Communications.

Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity.

B. Delahunt, D. Grignon, J. McKenney, 2014, The American journal of surgical pathology.

The assessment of catheter-induced urethritis using an experimental dog model.

B. Delahunt, J. Nacey, A. G. Tulloch, 1985, The Journal of urology.

Dissecting memory T cell responses to TB: concerns using adoptive transfer into immunodeficient mice.

B. Delahunt, Lindsay R. Ancelet, J. Kirman, 2012, Tuberculosis.

Acute pancreatitis severity is exacerbated by intestinal ischemia-reperfusion conditioned mesenteric lymph.

B. Delahunt, J. Windsor, G. Cooper, 2008, Surgery.

Light and scanning electron microscopic changes observed in experimental arterial forks of rabbits.

B. Delahunt, W. Stehbens, B. J. Martin, 1991, International journal of experimental pathology.

The Lung Is an Important Site for Priming CD4 T-Cell-Mediated Protective Immunity against Gastrointestinal Helminth Parasites

B. Delahunt, W. Paul, M. Camberis, 2010, Infection and Immunity.

The epigenome: key to understanding and predicting gout flares.

B. Delahunt, T. J. Major, M. Thunders, 2021, Pathology.

Early organ-specific mitochondrial dysfunction of jejunum and lung found in rats with experimental acute pancreatitis.

B. Delahunt, J. Windsor, G. Cooper, 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy

P. Ström, B. Delahunt, H. Samaratunga, 2020, Journal of Clinical Pathology.

Takayasu's disease associated with generalised amyloidosis.

B. Delahunt, W. Austad, A. Graham, 1985, Australian and New Zealand journal of medicine.

Tumors of pineal parenchymal cells: a correlation of histological features, including nucleolar organizer regions, with survival in 35 cases.

B. Delahunt, E. Rushing, W. Mccarthy, 1995, Human pathology.

Redox status of acute pancreatitis as measured by cyclic voltammetry: Initial rodent studies to assess disease severity*

B. Delahunt, J. Windsor, G. Cooper, 2008, Critical care medicine.

Use of the ISUP e-learning module improves interrater reliability in prostate cancer grading

B. Delahunt, T. H. van der Kwast, H. Samaratunga, 2022, Journal of clinical pathology.

Infiltration By Immunocompetent Cells In Early Stage Invasive Carcinoma Of The Uterine Cervix: A prognostic study

B. Delahunt, P. Bethwaite, L. Holloway, 1996, Pathology.

Testicular lipomatosis in Cowden's syndrome

B. Delahunt, M. Ferguson, J. Woodhouse, 2005, Modern Pathology.

Renal Neoplasia: WHO 2003. The Increasing Influence of Molecular Pathology

B. Delahunt, 2003 .

Clear Cell Tubulopapillary Renal Cell Carcinoma: A Study of 36 Distinctive Low-grade Epithelial Tumors of the Kidney

B. Delahunt, C. Magi-Galluzzi, Ming Zhou, 2010, The American journal of surgical pathology.

Computerized Nuclear Morphometry And Survival In Renal Cell Carcinoma: Comparison With Other Prognostic Indicators

B. Delahunt, R. Becker, P. Bethwaite, 1994, Pathology.

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens: rationale and organization

Lars Egevad, Brett Delahunt, B. Delahunt, 2011, Modern Pathology.

[Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)].

B. Delahunt, G. Kristiansen, J. Srigley, 2015, Der Pathologe.

The International Society of Urological Pathology Consensus Conference regarding the classification, prognostic factors, staging, and immunohistochemical and molecular assessment of adult renal tumors

B. Delahunt, J. Srigley, L. Egevad, 2015 .

Vancouver-Klassifikation von Nierentumoren

B. Delahunt, G. Kristiansen, J. Srigley, 2014, Der Pathologe.

International Society of Urological Pathology grading and other prognostic factors for renal neoplasia.

B. Delahunt, J. Srigley, L. Egevad, 2014, European urology.

Advances in renal neoplasia: recommendations from the 2012 International Society of Urological Pathology Consensus Conference.

B. Delahunt, J. Srigley, L. Egevad, 2014, Urology.

Wilms' tumour in New Zealand 1960-1986.

B. Delahunt, J. Nacey, P. Bethwaite, 1992, British journal of urology.

Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction

P. Ruusuvuori, B. Delahunt, H. Samaratunga, 2022, Nature communications.

Ischaemic necrosis of the glans penis: a complication of urethral catheterization in a diabetic man.

B. Delahunt, J. Nacey, T. J. Neale, 1990, The Australian and New Zealand journal of surgery.

Infection of mice with Mycobacterium bovis-BCG induces both Th1 and Th2 immune responses in the absence of interferon-gamma signalling.

B. Delahunt, G. Le Gros, H. Moll, 1999, European cytokine network.

5-Alpha reductase inhibitors and PSA screening for prostate cancer.

B. Delahunt, J. Kench, K. Sikaris, 2014, Pathology.

Renal cell carcinoma in New Zealand: a national survival study.

B. Delahunt, J. Nacey, P. Bethwaite, 1994, Urology.

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

Lars Egevad, Holger Moch, Jonathan I. Epstein, 2013, The American journal of surgical pathology.

The Heidelberg classification of renal cell tumours

Holger Moch, Peter Bugert, Göran Roos, 1997, The Journal of pathology.

Classification of renal cell carcinoma

B. Delahunt, D. Bostwick, K. Iczkowski, 1997, Cancer.

Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer

J. Cheville, B. Delahunt, D. Grignon, 2015, Modern Pathology.

Tumour-like lesions of the urinary bladder.

B. Delahunt, H. Samaratunga, L. Egevad, 2020, Pathology.

Microwave sterilization of polyethylene catheters for intermittent self-catheterization.

B. Delahunt, J. Nacey, D. Griffith, 1993, The Australian and New Zealand journal of surgery.

HLA-DRB1 and HLA-DQB1 polymorphisms in Pacific Islands populations.

B. Delahunt, J. Carter, Z. Velickovic, 2002, Tissue antigens.

Dataset for the reporting of urinary tract carcinoma—biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR)

B. Delahunt, D. Grignon, T. H. van der Kwast, 2019, Modern Pathology.

Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR)

B. Delahunt, H. Samaratunga, J. Srigley, 2019, Histopathology.

Immunohistochemical profile of ductal adenocarcinoma of the prostate

B. Delahunt, H. Samaratunga, J. Lindberg, 2014, Virchows Archiv.

Thyroid gland clonality revisited: the embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution.

B. Delahunt, N. Eberhardt, L. Jovanovic, 2003, The Journal of clinical endocrinology and metabolism.

Mesenchymal tumors of adult kidney.

B. Delahunt, H. Samaratunga, 2015, Seminars in diagnostic pathology.

Best Practices Recommendations in the Application of Immunohistochemistry in Urologic Pathology: Report From the International Society of Urological Pathology Consensus Conference

B. Delahunt, D. Berney, D. Grignon, 2014, The American journal of surgical pathology.

Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.

B. Delahunt, H. Samaratunga, N. Dunglison, 2012, Anticancer research.

Nucleolar organizer regions in seminoma and intratubular malignant germ cells.

B. Delahunt, F. Mostofi, I. Sesterhenn, 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Gold toning improves the visualization of nucleolar organizer regions in paraffin embedded tissues.

B. Delahunt, F. Mostofi, J. Ribas, 1991, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

Nucleolar organiser regions in renal tumours.

B. Delahunt, J. Nacey, W. Frater, 1990, Journal of Clinical Pathology.

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease

Rodolfo Montironi, Brett Delahunt, Cristina Magi-Galluzzi, 2011, Modern Pathology.

Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy

B. Delahunt, I. Hermans, G. Painter, 2021, Frontiers in Immunology.

Broadsheet number 45: Thin core biopsy of prostate

B. Delahunt, J. Nacey, 1998, Pathology.

Testicular germ cell tumor with pineal metastases.

B. Delahunt, J. Nacey, V. Balakrishnan, 1990, Neurosurgery.

Variation in AgNOR scores for renal cell carcinoma.

B. Delahunt, J. Nacey, P. Bethwaite, 1992, The Journal of pathology.

RENAL CELL CARCINOMA II. HISTOLOGICAL INDICATORS OF PROGNOSIS

B. Delahunt, J. Nacey, 1987, Pathology.

Diffuse malignant mesothelioma arising in a paracolostomy hernial sac

B. Delahunt, P. Bethwaite, C. A. Teague, 1996, Histopathology.

Advances and controversies in grading and staging of renal cell carcinoma

B. Delahunt, 2009, Modern Pathology.

Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour

B. Delahunt, J. Eble, J. Nacey, 2000, Histopathology.

Chromosome 14q LOH in localized clear cell renal cell carcinoma

B. Delahunt, M. McCredie, A. Reeve, 2002, The Journal of pathology.

Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma

B. Delahunt, M. McCredie, A. Reeve, 2002, Cancer.

Nucleolar organizing regions in renal cell carcinoma, renal oncocytoma and renal adenoma.

B. Delahunt, J. Nacey, W. Frater, 1989, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

Proliferation kinetics of streptozotocin-induced renal tumours in mice

B. Delahunt, P. Cartwright, P. Dady, 2004, Virchows Archiv.

Expanding the Histologic Spectrum of Mucinous Tubular and Spindle Cell Carcinoma of the Kidney

B. Delahunt, P. Argani, V. Reuter, 2006, The American journal of surgical pathology.

Perithyroidal Salivary Gland Acinic Cell Carcinoma: Morphological and Molecular Attributes of a Unique Lesion

B. Delahunt, H. Samaratunga, L. Egevad, 2020, Head and Neck Pathology.

Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma

B. Delahunt, Liang Cheng, J. Eble, 2006, Modern Pathology.

Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations.

B. Delahunt, G. Kristiansen, H. Samaratunga, 2018, Pathology.

Genetic profile of ductal adenocarcinoma of the prostate.

B. Delahunt, H. Samaratunga, J. Lindberg, 2017, Human pathology.

Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de‐differentiation

B. Delahunt, H. Samaratunga, L. Egevad, 2016, Histopathology.

Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

B. Delahunt, P. Humphrey, J. Kench, 2019, Pathology.

Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens

B. Delahunt, J. Kench, H. Samaratunga, 2011, Pathology.

Molecular Genetic Evidence for the Independent Origin of Multifocal Papillary Tumors in Patients with Papillary Renal Cell Carcinomas

B. Delahunt, Liang Cheng, G. MacLennan, 2005, Clinical Cancer Research.

Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists

B. Delahunt, D. Berney, D. Grignon, 2014, Histopathology.

Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin

B. Delahunt, H. Samaratunga, J. Lindberg, 2022, The Prostate.

Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.

B. Delahunt, A. Evans, J. Kench, 2019, Pathology.

Many facets of chromosome 3p cytogenetic findings in clear cell renal carcinoma: the need for agreement in assessment FISH analysis to avoid diagnostic errors.

B. Delahunt, Liang Cheng, J. Eble, 2011, Histology and histopathology.

Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families.

B. Delahunt, L. Aaltonen, T. Visakorpi, 2002, Cancer research.

Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors.

B. Delahunt, C. Porta, A. Scarpa, 2014, American journal of cancer research.

Best Practices Recommendations in the Application of Immunohistochemistry in the Kidney Tumors: Report From the International Society of Urologic Pathology Consensus Conference

B. Delahunt, P. Argani, V. Reuter, 2014, The American journal of surgical pathology.

Pathology of the renal pelvis and ureter

B. Delahunt, H. Samaratunga, 2013 .

Pregnancy-associated arterio-venous malformations of the uterus

B. Delahunt, J. Smalldridge, P. Stone, 1996 .

Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial

B. Delahunt, H. Samaratunga, J. Srigley, 2020, Histopathology.

Renal Cell Neoplasms of Oncocytosis Have Distinct Morphologic, Immunohistochemical, and Cytogenetic Profiles

B. Delahunt, D. Grignon, H. Samaratunga, 2010, The American journal of surgical pathology.

Gleason grading: past, present and future

Brett Delahunt, B. Delahunt, A. Evans, 2012, Histopathology.

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge

Po-Hsuan Cameron Chen, David F. Steiner, G. Corrado, 2022, Nature Medicine.

Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists

Daan Nieboer, Liang Cheng, Lars Egevad, 2016, Histopathology.

Percutaneous renal tumour biopsy

B. Delahunt, A. Evans, H. Samaratunga, 2014, Histopathology.

Les tumeurs rénales: Recommandations de la conférence de consensus de I'International Society of Urologic Pathology (ISUP) 2012

J. Cheville, B. Delahunt, P. Humphrey, 2014 .

Handling and Staging of Renal Cell Carcinoma: The International Society of Urological Pathology Consensus (ISUP) Conference Recommendations

B. Delahunt, D. Grignon, H. Samaratunga, 2013, The American journal of surgical pathology.

Type 2 and clear cell papillary renal cell carcinoma, and tubulocystic carcinoma: a unifying concept.

B. Delahunt, J. Srigley, C. Whelan, 2010, Anticancer research.

Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma

B. Delahunt, Liang Cheng, J. Eble, 2005, Modern Pathology.

RENAL CELL NEOPLASIA

B. Delahunt, J. Eble, 2002, Pathology.

Evolving classification of renal cell neoplasia

B. Delahunt, M. Velickovic, Stefan KG Grebe, 2001, Expert review of anticancer therapy.

Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features.

B. Delahunt, H. Samaratunga, L. Egevad, 2016, Pathology.

Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.

B. Delahunt, H. Samaratunga, J. Yaxley, 2010, Human pathology.

Familial cystic nephroma and pleuropulmonary blastoma

B. Delahunt, J. Nacey, P. Meffan, 1993, Cancer.

FAMILIAL CYSTIC NEPHROMA AND PLEUROPULMONARY BLASTOMA. AUTHOR'S REPLY

B. Delahunt, A. Verdeguer, C. Esquembre, 1993 .

Familial cystic nephroma and pleuropulmonary blastoma

B. Delahunt, A. Verdeguer, C. Esquembre, 1993, Cancer.

Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus.

B. Delahunt, S. Grebe, M. Velickovic, 1999, Cancer research.

A novel technique for biobanking of large sections of radical prostatectomy specimens

B. Delahunt, H. Samaratunga, J. Lindberg, 2018, Histopathology.

Therapy‐associated effects in the prostate gland

B. Delahunt, J. Srigley, A. Evans, 2012, Histopathology.

Uncommon and recently described renal carcinomas

B. Delahunt, J. Srigley, 2009, Modern Pathology.

Optimising restriction enzyme cleavage of DNA derived from archival histopathological samples: an improved HUMARA assay

B. Delahunt, N. Eberhardt, L. Jovanovic, 2003, Pathology.

Biomarkers in renal cancer

Lars Egevad, Holger Moch, Rodolfo Montironi, 2014, Virchows Archiv.

Mixed Epithelial and Stromal Tumor of the Kidney: A Clinicopathologic Study of 53 Cases

B. Delahunt, D. Grignon, J. Eble, 2016, The American journal of surgical pathology.

International Society of Urological Pathology (ISUP) grading of prostate cancer – An ISUP consensus on contemporary grading

B. Delahunt, H. Samaratunga, J. Srigley, 2016, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with 68Ga-PSMA Positron Emission Tomography/Computerized Tomography Compared to Histological Correlation of Pelvic Lymph Node Pathology

B. Delahunt, L. Egevad, J. Yaxley, 2019, The Journal of urology.

Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma

B. Delahunt, N. Eberhardt, R. Lea, 2010, Pathology.

Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma.

B. Delahunt, P. Bethwaite, A. Thornton, 1997, British Journal of Urology.

History of Renal Neoplasia

B. Delahunt, 2009 .

Renal neoplasia: From morphologic to molecular diagnosis.

B. Delahunt, J. Srigley, 2015, Seminars in diagnostic pathology.

Renal cell carcinoma with smooth muscle stroma lacks chromosome 3p and VHL alterations

B. Delahunt, S. Knuutila, Liang Cheng, 2014, Modern Pathology.

Effective maybe, but is it cost‐effective? A reply

B. Delahunt, H. Samaratunga, J. Nacey, 2014, Histopathology.

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes

B. Delahunt, D. Berney, D. Grignon, 2011, Modern Pathology.

Renal Tumors: Diagnostic and Prognostic Biomarkers

B. Delahunt, D. Grignon, J. Srigley, 2013, The American journal of surgical pathology.

The ISUP system of staging, grading and classification of renal cell neoplasia

B. Delahunt, H. Samaratunga, T. Gianduzzo, 2014, Journal of kidney cancer and VHL.

Grading of Clear Cell Renal Cell Carcinoma Should be Based on Nucleolar Prominence

B. Delahunt, H. Samaratunga, J. Srigley, 2011, The American journal of surgical pathology.

Fuhrman Grading is not Appropriate for Chromophobe Renal Cell Carcinoma

B. Delahunt, Dianne Sika-Paotonu, M. McCredie, 2007, The American journal of surgical pathology.

VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.

B. Delahunt, M. Velickovic, S. Störkel, 2001, Cancer research.

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques

B. Delahunt, H. Samaratunga, J. Srigley, 2017, World Journal of Urology.

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.

B. Delahunt, C. Oldmeadow, J. Attia, 2014, The Lancet. Oncology.

Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist

M. Rubin, A. Chinnaiyan, B. Delahunt, 2014, Virchows Archiv.

The ependyma of the saccular pineal gland in the non-eutherian mammal Trichosurus vulpecula

B. Delahunt, D. Samarasinghe, 1980, Cell and Tissue Research.

The Impact of Intestinal Ischaemia-Reperfusion on Caerulein-Induced Oedematous Experimental Pancreatitis

B. Delahunt, J. Windsor, F. Abu-Zidan, 2003, European Surgical Research.

Acute pancreatitis conditioned mesenteric lymph causes cardiac dysfunction in rats independent of hypotension

B. Delahunt, J. Windsor, M. Petrov, 2018, Surgery.

T1829 The Proteome of Mesenteric Lymph During Acute Pancreatitis and Implications for Treatment

B. Delahunt, J. Windsor, G. Cooper, 2009 .

The proteome of mesenteric lymph during acute pancreatitis and implications for treatment.

B. Delahunt, J. Windsor, G. Cooper, 2009, JOP : Journal of the pancreas.

Ultrastructure of streptozotocin — induced renal tumours in mice

B. Delahunt, J. St. John Wakefield, 1997, Virchows Archiv.

Editorial: Genitourinary pathology 120 years on.

B. Delahunt, 2003, Pathology.

Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma.

Holger Moch, Peter J Wild, Tullio Sulser, 2009, European urology.

Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter—Nephroureterectomy and Ureterectomy Specimens

B. Delahunt, T. H. van der Kwast, H. Samaratunga, 2019, The American journal of surgical pathology.

Fine‐needle aspiration cytology of metastatic clear‐cell renal carcinoma presenting as a solitary mass in the head of the pancreas

B. Delahunt, Raj K. Gupta, Shardu Lallu, 1998, Diagnostic cytopathology.

Histopathologic prognostic indicators for renal cell carcinoma.

B. Delahunt, Brett Delahunt, 1998, Seminars in diagnostic pathology.

The histopathology of endocardial sclerosis.

B. Delahunt, W. Stehbens, J. Zuccollo, 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies

P. Ruusuvuori, P. Ström, H. Olsson, 2021, Virchows Archiv.

Myxosarcoma of the right ventricle: an immunohistochemical and ultrastructural study.

B. Delahunt, D. Mchaffie, J. Wakefield, 2003, Anticancer research.

Sarcomatoid carcinoma of the prostate: progression from adenocarcinoma is associated with p53 over-expression.

B. Delahunt, J. Eble, J. Nacey, 1999, Anticancer research.

Monographs on pathology of laboratory animals: urinary system

B. Delahunt, 1999 .

Microvessel density as a prognostic marker for transitional cell carcinoma of the bladder.

B. Delahunt, C. Hawke, P. Davidson, 1998, British journal of urology.

A Novel Grading System for Clear Cell Renal Cell Carcinoma Incorporating Tumor Necrosis

Stephen A Boorjian, Brett Delahunt, J. Cheville, 2013, The American journal of surgical pathology.

Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker.

B. Delahunt, M. Fassan, S. Knuutila, 2017, Pathology (Sydney).

Data set for the reporting of carcinoma of renal tubular origin: recommendations from the International Collaboration on Cancer Reporting (ICCR)

B. Delahunt, A. Evans, J. Srigley, 2019, Histopathology.

Dataset for the reporting of carcinoma of renal tubular origin

B. Delahunt, P. Camparo, Ming Zhou, 2018 .

Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology

B. Delahunt, D. Berney, G. Kristiansen, 2011, Journal of Clinical Pathology.

Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype

B. Delahunt, J. Nacey, P. Bethwaite, 2007, Pathology.

Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability.

B. Delahunt, N. Eberhardt, I. Hay, 2002, The Journal of molecular diagnostics : JMD.

Proteins Annexin A2 and PSA in Prostate Cancer Biopsies Do Not Predict Biochemical Failure.

B. Delahunt, T. W. Jordan, J. Denham, 2017, Anticancer research.

Dataset for the reporting of renal biopsy for tumour: recommendations from the International Collaboration on Cancer Reporting (ICCR)

B. Delahunt, A. Evans, J. Srigley, 2019, Journal of Clinical Pathology.

Cystic embryonal sarcoma of kidney

B. Delahunt, J. Eble, J. Beckwith, 1998, Cancer.

Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases

B. Delahunt, D. Grignon, J. Eble, 2016, The American journal of surgical pathology.

Consensus guidelines for reporting prostate cancer Gleason Grade

B. Delahunt, H. Samaratunga, J. Srigley, 2016, BJU international.

The current status of renal cell carcinoma and prostate carcinoma grading

B. Delahunt, H. Samaratunga, L. Egevad, 2018, International braz j urol : official journal of the Brazilian Society of Urology.

Re: Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma: T. Klatte, C. Anterasian, J. W. Said, M. de Martino, F. F. Kabbinavar, A. S. Belldegrun and A. J. Pantuck J Urol 2010; 183: 2143-2147.

B. Delahunt, J. Srigley, Dianne Sika-Paotonu, 2011, The Journal of urology.

Tumours of the urethra

B. Delahunt, M. Amin, A. Hartmann, 2004 .

Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer in Biopsies-Current Status and Next Steps.

Po-Hsuan Cameron Chen, G. Litjens, P. Ruusuvuori, 2021, European urology focus.

Parameters of perineural invasion in radical prostatectomy specimens lack prognostic significance

B. Delahunt, P. Bethwaite, G. Russell, 2008, Modern Pathology.

Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra‐glandular spread of the initial neoplastic clone

B. Delahunt, N. Eberhardt, L. Jovanovic, 2008, The Journal of pathology.

Comparison Of Silver‐Staining Nucleolar Organizer Region (Agnor) Counts And Proliferating Cell Nuclear Antigen (Pcna) Expression In Reactive Mesothelial Hyperplasia And Malignant Mesothelioma

B. Delahunt, L. Holloway, A. Thornton, 1995, Pathology.

Prostate carcinoma and the Lambert-Eaton myasthenic syndrome.

B. Delahunt, D. Abernethy, J. Nacey, 2003, The Journal of urology.

Low‐risk prostate lesions: An evidence review to inform discussion on losing the “cancer” label

B. Delahunt, M. Varma, A. Barratt, 2023, The Prostate.

Low‐grade prostate cancer should still be labelled cancer

B. Delahunt, D. Berney, D. Bostwick, 2022, BJU international.

Utility of Pathology Imagebase for standardisation of prostate cancer grading

Toyonori Tsuzuki, Lars Egevad, Murali Varma, 2018, Histopathology.

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial.

B. Delahunt, C. Oldmeadow, J. Attia, 2020, International journal of radiation oncology, biology, physics.

Undiagnosed retroperitoneal mass. Report of a case in which needle aspiration cytodiagnosis led to investigation and timely management.

B. Delahunt, R. Gupta, A. Alansari, 1995, Acta Cytologica.

Cytodiagnosis of Hashimoto's thyroiditis associated with a metastatic adenocarcinoma

B. Delahunt, Raj K. Gupta, P. Johnston, 1996, Diagnostic cytopathology.

Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation.

B. Delahunt, A. Caliò, M. Brunelli, 2014, Annals of transplantation.

Renal dysplasia produced by obstructive uropathy in the fetal lamb

B. Delahunt, J. Zuccollo, K. Pringle, 2003, Pathology (Sydney).

Preoperative diagnosis of bilateral renal oncocytoma by needle aspiration cytology. A case report.

B. Delahunt, R. Gupta, J. Wakefield, 1991, Acta cytologica.

Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading

P. Ström, H. Olsson, B. Delahunt, 2020, Virchows Archiv.

Nodular pulmonary light chain deposition disease.

B. Delahunt, P. Russell, M. Yee, 2016, Pathology.

Vasectomy and risk of prostate cancer.

C. Paul, B. Delahunt, D. Skegg, 2002, JAMA.

Prostate cancer grading, time to go back to the future

B. Delahunt, D. Bostwick, A. Evans, 2020, BJU international.

Evolution, controversies and the future of prostate cancer grading

B. Delahunt, H. Samaratunga, L. Egevad, 2019, Pathology international.

From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer

B. Delahunt, H. Samaratunga, J. Srigley, 2016, Scandinavian journal of urology.

Late recurrence of renal solitary fibrous tumour in the contralateral kidney.

B. Delahunt, H. Samaratunga, L. Egevad, 2022, Pathology.

One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason grading.

B. Delahunt, A. Evans, H. Samaratunga, 2016, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting

B. Delahunt, P. Humphrey, J. Kench, 2019, Virchows Archiv.

Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting

B. Delahunt, P. Humphrey, J. Kench, 2013, Histopathology.

CHANGES IN THE MESENTERIC LYMPH PROTEOME INDUCED BY HEMORRHAGIC SHOCK

B. Delahunt, J. Windsor, G. Cooper, 2010, Shock.

Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast.

B. Delahunt, P. Bethwaite, D. Kenwright, 1998, Journal of clinical pathology.

breast the pathology of ductal carcinoma in situ of the Reproducibility of new classification schemes for

B. Delahunt, P. Bethwaite, D. Kenwright, 1998 .

Ovarian-type papillary serous cystadenocarcinoma of the testis.

B. Delahunt, J. Nacey, 1996, British journal of urology.

Toxicity study of first and second generation hydrogel-coated latex urinary catheters.

B. Delahunt, J. Nacey, 1991, British journal of urology.

The lung is an important site for priming CD 4 T cell mediated 2 protective immunity against gastrointestinal helminth parasites . 3 Running title : The lung is an important site for protective immunity against 4 parasites

B. Delahunt, W. Paul, M. Camberis, 2010 .

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume

Lars Egevad, Rodolfo Montironi, Mahul B Amin, 2011, Modern Pathology.

Multifocal anastomosing haemangioma of the kidney with intravascular growth and sinus fat invasion: a rare benign mimic of angiosarcoma.

B. Delahunt, J. Perry-Keene, Kiran Hazratwala, 2020, Pathology.

Prostate cancer: the new evidence base for diagnosis and treatment

B. Delahunt, D. Lamb, J. Nacey, 2007, Pathology.

Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans‐Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer

B. Delahunt, P. Moscato, P. McElduff, 2014, BJU international.

Histological comparison between predictive value of preoperative 3‐T multiparametric MRI and 68Ga‐PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer

B. Delahunt, H. Samaratunga, L. Egevad, 2020, BJU international.

Improving outcomes for New Zealand men with prostate cancer.

B. Delahunt, J. Nacey, S. Mark, 2014, The New Zealand medical journal.

Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy

B. Delahunt, F. Menestrina, M. Chilosi, 2010, Pathology.

The journal marches on

B. Delahunt, 2022, Pathology (Sydney).

Gleason scoring: a comparison of classical and modified (International Society of Urological Pathology) criteria using nadir PSA as a clinical end point

B. Delahunt, H. Samaratunga, J. Srigley, 2010, Pathology.

Awareness of testicular cancer in New Zealand men.

B. Delahunt, J. Nacey, M. Mackey, 1994, The Australian and New Zealand journal of surgery.

Publication metrics: it really is all about the numbers.

B. Delahunt, R. Scolyer, J. Burnett, 2021, Pathology.

Publication metrics: what do they mean?

B. Delahunt, R. Scolyer, J. Burnett, 2020, Pathology.

A further step on the journey.

B. Delahunt, 2009, Pathology.

Oncological and urinary outcomes following low‐dose‐rate brachytherapy with a median follow‐up of 11.8 years

B. Delahunt, H. Samaratunga, L. Egevad, 2022, BJU international.

Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade

Jeanne Shen, J. A. van der Laak, B. Delahunt, 2023, EBioMedicine.

The effect of finasteride on prostate volume, urinary flow rate and symptom score in men with benign prostatic hyperplasia.

B. Delahunt, J. Nacey, P. Meffan, 1995, The Australian and New Zealand journal of surgery.

Premalignant lesions of the urinary bladder.

B. Delahunt, H. Samaratunga, L. Egevad, 2013, Pathology.

Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.

B. Delahunt, A. Evans, D. Grignon, 2017, Archives of pathology & laboratory medicine.

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume

Lars Egevad, Brett Delahunt, Philippe Camparo, 2010, Modern Pathology.

Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial

B. Delahunt, H. Samaratunga, L. Egevad, 2021, Pathology.

Intraductal Carcinoma of the Prostate and Nuclear Size.

B. Delahunt, H. Samaratunga, L. Egevad, 2022, The American journal of surgical pathology.

Intraductal carcinoma of the prostate is not a diagnostic entity

B. Delahunt, J. Kench, T. H. van der Kwast, 2020, Histopathology.

Reply: ‘A plea for greater standardization in intraductal carcinoma of the prostate —greater standardization requires greater evidence’: let's use the available evidence

B. Delahunt, G. Kristiansen, M. Varma, 2017, Histopathology.

Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question.

B. Delahunt, T. H. van der Kwast, M. Varma, 2019, European urology.

Sampling of prostatic tissue.

B. Delahunt, H. Heng Teoh, 1990, Human pathology.

Rapid Diagnostic Screening of Prostatic Tissue by Low Power Microscopy

B. Delahunt, H. Teoh, 1994 .

Strongly Magnetic Iron Nanoparticles Improve the Diagnosis of Small Tumours in the Reticuloendothelial System by Magnetic Resonance Imaging

B. Delahunt, R. Tilley, I. Hermans, 2013, PloS one.

Accelerating the secondary immune response by inactivating CD4+CD25+ T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis

Kylie M. Quinn, B. Delahunt, G. D. de Lisle, 2008, European journal of immunology.

Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.

B. Delahunt, H. Samaratunga, L. Egevad, 2017, Pathology.

The decline of medical publishing: the rise of the pseudo-journal.

B. Delahunt, H. Samaratunga, L. Egevad, 2017, Pathology.

Detection of perineural invasion in prostate needle biopsies with deep neural networks pdf

Pekka Ruusuvuori, Martin Eklund, Lars Egevad, 2020, Virchows Archiv.

International Society of Urological Pathology Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens

B. Delahunt, J. Srigley, L. Egevad, 2011, Advances in anatomic pathology.

Utility of Reporting the Percentage of High-grade Prostate Cancer.

B. Delahunt, H. Samaratunga, J. Srigley, 2016, European urology.

Findings in 1123 Men with Pre-operative 68Ga-PSMA PET/CT and mpMRI Compared to Totally Embedded Radical Prostatectomy Histopathology. Implications for the Diagnosis and Management of Prostate Cancer.

B. Delahunt, H. Samaratunga, L. Egevad, 2021, The Journal of urology.

Urinary catheter toxicity.

B. Delahunt, J. Nacey, 1991, The New Zealand medical journal.

The assessment of urinary catheter toxicity using cell cultures: validation by comparison with an animal model.

B. Delahunt, D. Horsfall, V. Marshall, 1986, The Journal of urology.

Occupational risk for renal cell carcinoma. A case-control study based on the New Zealand Cancer Registry.

B. Delahunt, J. Nacey, P. Bethwaite, 1995, British journal of urology.

Gleason and Fuhrman no longer make the grade

B. Delahunt, H. Samaratunga, J. Srigley, 2016, Histopathology.

Oral shark cartilage does not abolish carcinogenesis but delays tumor progression in a murine model.

B. Delahunt, S. Grebe, P. Davis, 2001, Anticancer research.

Tumour grading: communication is the key

B. Delahunt, T. H. van der Kwast, M. Varma, 2023, Journal of Clinical Pathology.

Is the UICC/AJCC pT2 Staging Category for Clear Cell Renal Cell Carcinoma Meaningful?

B. Delahunt, H. Samaratunga, M. Varma, 2019, The American journal of surgical pathology.

Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma.

B. Delahunt, H. Samaratunga, M. Varma, 2019, Pathology.

Clinicopathologic Significance of Anterior Prostate Cancer

B. Delahunt, H. Samaratunga, L. Egevad, 2023, The American journal of surgical pathology.

Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 men

B. Delahunt, H. Samaratunga, J. Srigley, 2014, Pathology.

Urological pathology comes of age.

B. Delahunt, J. Srigley, L. Egevad, 2012, Pathology (Sydney).

Utility of tissue microarrays for assessment of chromosomal abnormalities in chromophobe renal cell carcinoma.

B. Delahunt, Liang Cheng, J. Eble, 2009, Analytical and quantitative cytology and histology.

FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma.

B. Delahunt, Liang Cheng, J. Eble, 2011, Anticancer research.

[Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations].

J. Cheville, B. Delahunt, D. Grignon, 2014, Annales de pathologie.

Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease

B. Delahunt, T. W. Jordan, D. Lamb, 2015, Clinical Proteomics.

The emerging role of artificial intelligence in the reporting of prostate pathology.

P. Ruusuvuori, B. Delahunt, H. Samaratunga, 2021, Pathology.

Tumours of the renal pelvis and ureter

B. Delahunt, M. Amin, A. Hartmann, 2004 .

Polyclonal Ki‐67 expression in transitional cell carcinoma of the bladder

B. Delahunt, P. Bethwaite, A. Thornton, 1997, Pathology.

Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1

J. Logan, B. Delahunt, H. Samaratunga, 2023, Cancers.

The Heidelberg classification of renal cell tumours

B. Delahunt, J. Srigley, C. Cooper, 1997, The Journal of pathology.

Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000–2012

Pär Stattin, David Robinson, Brett Delahunt, 2017, BJU international.

Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 ‘RADAR’ trial clinical data

B. Delahunt, J. Srigley, L. Egevad, 2015, Pathology.

Progeria kidney has abnormal mesangial collagen distribution

B. Delahunt, E. Gilbert-Barness, W. Stehbens, 2000, Pediatric Nephrology.

Volatile N-nitrosamines in urinary catheters.

B. Delahunt, J. Nacey, S. Dickson, 1989, British journal of urology.

Benign Solid and Acinar Mesothelioma (Adenomatoid Tumor)

B. Delahunt, D. Kenwright, 2005 .

Paratesticular Adenomatoid Tumor: Assessment of Calretinin Immunoexpression and Cell Proliferation Indices

B. Delahunt, J. Srigley, J. Eble, 2000 .

Somatic alterations detected in diagnostic prostate biopsies provide an inadequate representation of multifocal prostate cancer

B. Delahunt, H. Samaratunga, J. Lindberg, 2019 .

Pathologist-Level Grading of Prostate Biopsies with Artificial Intelligence pdf

Ming Zhou, Toyonori Tsuzuki, Pekka Ruusuvuori, 2019, ArXiv.

ISUP Consensus Definition of Cribriform Pattern Prostate Cancer

B. Delahunt, D. Berney, A. Evans, 2021, The American journal of surgical pathology.

Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.007: Should Chromophobe Renal Cell Carcinom

B. Delahunt, H. Samaratunga, L. Egevad, 2021, European Urology.

Letters to the Editor

B. Delahunt, J. Nacey, P. Bethwaite, 1951, The Journal of emergency medicine.

Prostate cancer--are ethnic minorities disadvantaged?

B. Delahunt, D. Lamb, J. Murray, 2008, Anticancer research.

Pathology Imagebase—a reference image database for standardization of pathology

Lars Egevad, Mark Clements, James G Kench, 2017, Histopathology.

Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread.

B. Delahunt, H. Samaratunga, L. Karageorgos, 2023, Pathology (Sydney).

Prostate cancer grading: recent developments and future directions

B. Delahunt, D. Grignon, H. Samaratunga, 2016, BJU international.

Giant sclerosing leiomyoma of bladder presenting as chronic renal failure.

B. Delahunt, J. Nacey, A. Ferguson, 1991, Urology.

The International Society of Urological Pathology Education web—a web-based system for training and testing of pathologists

Toyonori Tsuzuki, Lars Egevad, Mark Clements, 2019, Virchows Archiv.

THE NEW ZEALAND THE NEW ZEALAND THE NEW ZEALAND THE NEW ZEALAND THE NEW ZEALAND MEDICAL JOURNAL MEDICAL

B. Delahunt, A. V. Rij, B. Smaill, 2005 .

Reply to Eva Compérat, Mahul Amin, Victor Reuter's Editorial Reply re: Murali Varma, Brett Delahunt, Theodorus van der Kwast. Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.05.001: Precis

B. Delahunt, M. Varma, T. Kwast, 2019, European urology.

Pathology 50 years on.

B. Delahunt, Belinda Neill, 2018, Pathology.

Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology

B. Delahunt, D. Berney, G. Kristiansen, 2011, Journal of Clinical Pathology.

M. Rubin, A. Chinnaiyan, B. Delahunt, 2014, Archives of pathology & laboratory medicine.

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques

B. Delahunt, H. Samaratunga, J. Srigley, 2017, World Journal of Urology.

From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer

B. Delahunt, H. Samaratunga, J. Srigley, 2016, Scandinavian journal of urology.

The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer

B. Delahunt, H. Samaratunga, L. Egevad, 2015, Pathology.

Optimising pre-analytical factors affecting quality of prostate biopsies: the case for site specific labelling and single core submission.

B. Delahunt, A. Evans, H. Samaratunga, 2014, Pathology.

Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma.

B. Delahunt, J. Patard, F. Montorsi, 2009, European urology.

Colonic varices

B. Delahunt, W. Isbister, C. W. Pease, 1989, Diseases of the colon and rectum.

Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker.

B. Delahunt, M. Fassan, S. Knuutila, 2017, Pathology.

Fuhrman grading is inappropriate for papillary renal cell carcinoma

B. Delahunt, H. Samaratunga, J. Srigley, 2018, World Journal of Urology.

Acute pancreatitis severity is exacerbated by intestinal ischemia-reperfusion conditioned mesenteric lymph.

B. Delahunt, J. Windsor, A. Phillips, 2008, Surgery.

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins

B. Delahunt, P. Humphrey, J. Srigley, 2011, Modern Pathology.

Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin.

A. Renshaw, B. Delahunt, D. Grignon, 2010, Archives of pathology & laboratory medicine.

Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity.

B. Delahunt, D. Grignon, J. McKenney, 2014, The American journal of surgical pathology.

Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting

B. Delahunt, P. Humphrey, J. Kench, 2013, Histopathology.

International Society of Urological Pathology grading and other prognostic factors for renal neoplasia.

B. Delahunt, J. Srigley, L. Egevad, 2014, European urology.

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens: rationale and organization

B. Delahunt, J. Srigley, L. Egevad, 2011, Modern Pathology.

Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading

P. Ström, H. Olsson, B. Delahunt, 2020, Virchows Archiv.

International Society of Urological Pathology (ISUP) grading of prostate cancer – An ISUP consensus on contemporary grading

B. Delahunt, H. Samaratunga, J. Srigley, 2016, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists

B. Delahunt, D. Berney, P. Humphrey, 2015, Histopathology.